The combined value of the women’s reproductive health pharmaceutical market is currently over $20 billion. A positive growth rate of 8 per cent is expected per annum for the next five years, according to It Publishing of London. An expanded variety of contraceptive choices for women is driving growth, as is continued growth in the gonadotrophins class for infertility.
Negative press regarding the side effects associated with hormone replacement therapy (HRT) has slowed this market down slightly, leaving a vaccum of market share for other osteoporosis therapies. HRT will, however, rebound during the forecast period and re-achieve strong growth.
Women’s Reproductive Health 2004 is arranged to provide an overview of this complex market. Specific attention is given to the following areas :
Contraception
Infertility
Osteoporosis/
Analysis and financial forecasts in these markets take into account many factors including:
Consumer preference statistics
Product differentiation
New indications
Patent expirations
Generic competition
The Women’s Health Institute HRT Study
Emerging markets, eg. Japan
Detailed financial information and forecasting is also provided for each chapter including in-depth coverage of drugs in the infertility and osteoporosis drug markets such as :
Gonadotrophins
Bisphosphonates
Selective estrogen receptor modulators
GnRH Antagonists
Hormone replacement therapy
Detailed product differentiation and financial analysis is presented for the following contraceptive products:
Hormonal contraceptives
Intra-uterine devices
Transdermal patches
Depot contraceptives
Emergency contraception
Analysis includes the use of charts and graphs measuring product growth and trends within the women’s reproductive health marketplace. Company-specific information, including sales figures, drug pipeline status, and research and development trends is provided throughout the report. Five-year financial forecasts are also provided
For more information, kindly visit :
http://www.bharatbook.com/
______________________________________________
